SYMBRAVO 20 mg/1
meloxicam, rizatriptan · TABLET · Axsome Therapeutics, Inc.
No Recall History
Plain English
SYMBRAVO is a tablet containing meloxicam, rizatriptan at 20 mg/1, taken oral. Manufactured by Axsome Therapeutics, Inc..
Key Facts
- Brand Name
- SYMBRAVO
- Generic Name
- meloxicam, rizatriptan
- NDC Code (Product)
81968-020- Manufacturer
- Axsome Therapeutics, Inc.
- Strength
- 20 mg/1
- Dosage Form
- TABLET
- Route
- ORAL
- Marketing Status
- Application #
- NDA215431
- Drug Class
- Nonsteroidal Anti-inflammatory Drug [EPC]
- Marketing Start
- 05/19/2025
Recall History
No Recall HistoryFrequently Asked Questions
What is SYMBRAVO used for?
SYMBRAVO contains meloxicam, rizatriptan. It is a tablet taken oral. Consult your doctor for specific uses.
Is SYMBRAVO a controlled substance?
SYMBRAVO is not classified as a controlled substance by the DEA.
What is the generic name for SYMBRAVO?
The generic name for SYMBRAVO is meloxicam, rizatriptan. There are no other listed brand versions of meloxicam, rizatriptan.
What is the NDC code for SYMBRAVO 20 mg/1?
The NDC (National Drug Code) for SYMBRAVO 20 mg/1 is 81968-020, listed by Axsome Therapeutics, Inc..
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)